Home Decipher Biosciences

Decipher Biosciences

acquired
-
Cancer Genomics Diagnostic Platform

Basic Information

Decipher Biosciences uses a disruptive genomic platform to optimize treatment for cancer patients, thereby improving patient care and enhancing quality of life. The company's vision is to become a leading global provider of cancer genomic medicine.
Decipher Biosciences Inc.
SanDiego,California,United States of America
51~100 people
January 01, 2008
cs@decipherbio.com